Heart-on-a-Chip Technology Directly Measures In-Vivo Cardiac Performance
At the AHA Scientific Sessions in Philadelphia, data from a study of investigational candidate, MYK-491, showed that a human iPSC-derived organ-on-a-chip... Read more
ORION-10 Trial: Inclisiran Effective at Reducing LDL
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol,... Read more
ENCOURAGE Trial - Simple Nudges Improve Statin Prescription Adherence
Statins are an effective medication for treating patients with heart disease. They cut the risk of a second major adverse cardiac event by almost... Read more
Intensive Glycaemic Control in Patients with Type 2 Diabetes
Type 2 diabetes is very common not only in North America, but globally. The disorder can lead to severe limb and life-threatening complications... Read more
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions and leads... Read more
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
Robots were first used in cardiovascular medicine in the late 1990s as a part of the digital revolution . Since then, robotics have been applied to endovascular surgery, minimally invasive cardiac surgery, and interventional cardiology, to name a few fields. Robots give medical professionals the ability to diagnose, treat, and intervene more... Read more
Finance, Skills Gap, Governance: Addressing CIO Challenges
Summary: With finance, skills and strategy all obstacles for the healthcare... Read more
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...